학술논문
Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2.
Document Type
Article
Author
Source
Drug Research; Jul2023, Vol. 73 Issue 6, p341-348, 8p
Subject
Language
ISSN
21949379